Financhill
Sell
49

RCKY Quote, Financials, Valuation and Earnings

Last price:
$22.79
Seasonality move :
6.6%
Day range:
$22.04 - $23.16
52-week range:
$19.65 - $40.14
Dividend yield:
2.72%
P/E ratio:
12.83x
P/S ratio:
0.38x
P/B ratio:
0.75x
Volume:
48.1K
Avg. volume:
45.1K
1-year change:
-20.94%
Market cap:
$170.2M
Revenue:
$461.8M
EPS (TTM):
$1.78
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $270.4M $277.3M $514.2M $615.5M $461.8M
Revenue Growth (YoY) 7.01% 2.55% 85.44% 19.69% -24.96%
 
Cost of Revenues $172.7M $172.6M $319.7M $390.3M $283.2M
Gross Profit $97.7M $104.7M $194.5M $225.2M $178.6M
Gross Profit Margin 36.13% 37.77% 37.83% 36.59% 38.67%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $146K -- -- -- --
Operating Expenses $75.6M $77.6M $158.6M $181.2M $143.2M
Operating Income $22.1M $27.2M $36M $44M $35.4M
 
Net Interest Expenses -- $205K $10.6M $18.3M $21.2M
EBT. Incl. Unusual Items $22.2M $27M $25.4M $25.8M $14.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $4.8M $6M $4.8M $5.3M $3.7M
Net Income to Company $17.5M $21M $20.6M $20.5M $10.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $17.5M $21M $20.6M $20.5M $10.4M
 
Basic EPS (Cont. Ops) $2.36 $2.87 $2.82 $2.80 $1.42
Diluted EPS (Cont. Ops) $2.35 $2.86 $2.77 $2.78 $1.41
Weighted Average Basic Share $7.4M $7.3M $7.3M $7.3M $7.4M
Weighted Average Diluted Share $7.4M $7.3M $7.4M $7.4M $7.4M
 
EBITDA $27.1M $32.4M $47.3M $56.4M $46.4M
EBIT $22.1M $27.2M $36M $44M $35.4M
 
Revenue (Reported) $270.4M $277.3M $514.2M $615.5M $461.8M
Operating Income (Reported) $22.1M $27.2M $36M $44M $35.4M
Operating Income (Adjusted) $22.1M $27.2M $36M $44M $35.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $77.8M $125.5M $147.5M $125.6M $114.6M
Revenue Growth (YoY) 15.79% 61.35% 17.51% -14.83% -8.81%
 
Cost of Revenues $48M $78.5M $95.6M $79.1M $70.9M
Gross Profit $29.8M $47M $51.9M $46.5M $43.6M
Gross Profit Margin 38.35% 37.42% 35.21% 37.05% 38.1%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -$55K -- -- -- --
Operating Expenses $20.2M $44.2M $40.3M $32.3M $33.6M
Operating Income $9.7M $2.8M $11.6M $14.3M $10.1M
 
Net Interest Expenses -- $3.2M $4.2M $5.6M $3.2M
EBT. Incl. Unusual Items $9.6M -$488K $7.4M $8.6M $6.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2M -$113K $1.8M $1.8M $1.6M
Net Income to Company $7.6M -$374K $5.7M $6.8M $5.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $7.6M -$375K $5.7M $6.8M $5.3M
 
Basic EPS (Cont. Ops) $1.04 -$0.05 $0.78 $0.93 $0.71
Diluted EPS (Cont. Ops) $1.04 -$0.05 $0.77 $0.93 $0.70
Weighted Average Basic Share $7.3M $7.4M $7.3M $7.4M $7.4M
Weighted Average Diluted Share $7.3M $7.4M $7.3M $7.4M $7.5M
 
EBITDA $10.9M $5.4M $14.5M $17M $12.7M
EBIT $9.7M $2.8M $11.6M $14.3M $10.1M
 
Revenue (Reported) $77.8M $125.5M $147.5M $125.6M $114.6M
Operating Income (Reported) $9.7M $2.8M $11.6M $14.3M $10.1M
Operating Income (Adjusted) $9.7M $2.8M $11.6M $14.3M $10.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $265M $432.4M $646M $474.8M $451.7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $168.2M $265M $414.2M $290.2M $275.1M
Gross Profit $96.9M $167.4M $231.8M $184.6M $176.6M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -$126K -- -- -- --
Operating Expenses $75.9M $136.7M $183.2M $150.3M $139.3M
Operating Income $20.9M $30.7M $48.6M $34.3M $37.3M
 
Net Interest Expenses -- $7.4M $15.6M $21.8M $19.2M
EBT. Incl. Unusual Items $20.8M $23.2M $33M $12.5M $18.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $4.5M $5.5M $6.5M $2.2M $4.8M
Net Income to Company $16.3M $17.7M $26.5M $10.2M $13.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $16.3M $17.7M $26.5M $10.2M $13.3M
 
Basic EPS (Cont. Ops) $2.22 $2.44 $3.63 $1.40 $1.79
Diluted EPS (Cont. Ops) $2.21 $2.41 $3.57 $1.40 $1.78
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $26M $40.3M $60.5M $46.1M $47.8M
EBIT $20.9M $30.7M $48.6M $34.3M $37.3M
 
Revenue (Reported) $265M $432.4M $646M $474.8M $451.7M
Operating Income (Reported) $20.9M $30.7M $48.6M $34.3M $37.3M
Operating Income (Adjusted) $20.9M $30.7M $48.6M $34.3M $37.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $189.7M $344.8M $476.6M $335.9M $325.7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $121.1M $213.5M $308M $208M $199.9M
Gross Profit $68.6M $131.3M $168.5M $127.9M $125.8M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -$112K -- -- -- --
Operating Expenses $54.3M $113.5M $138.1M $107.2M $103.3M
Operating Income $14.3M $17.8M $30.4M $20.6M $22.6M
 
Net Interest Expenses -- $7.4M $12.4M $15.9M $14M
EBT. Incl. Unusual Items $14.2M $10.4M $18M $4.7M $8.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.9M $2.4M $4.1M $979K $2M
Net Income to Company $11.2M $8M $14M $3.7M $6.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $11.2M $8M $14M $3.7M $6.6M
 
Basic EPS (Cont. Ops) $1.53 $1.10 $1.91 $0.51 $0.88
Diluted EPS (Cont. Ops) $1.53 $1.08 $1.88 $0.51 $0.87
Weighted Average Basic Share $22M $21.9M $21.9M $22.1M $22.3M
Weighted Average Diluted Share $22.1M $22.2M $22.1M $22.1M $22.4M
 
EBITDA $18.1M $26M $39.2M $28.9M $30.4M
EBIT $14.3M $17.8M $30.4M $20.6M $22.6M
 
Revenue (Reported) $189.7M $344.8M $476.6M $335.9M $325.7M
Operating Income (Reported) $14.3M $17.8M $30.4M $20.6M $22.6M
Operating Income (Adjusted) $14.3M $17.8M $30.4M $20.6M $22.6M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $15.5M $28.4M $5.9M $5.7M $4.5M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $45.6M $48M $126.8M $95M $77M
Inventory $76.7M $77.6M $232.5M $235.4M $169.2M
Prepaid Expenses $3M $3.7M $4.5M $4.1M $3.4M
Other Current Assets -- -- -- -- --
Total Current Assets $146.1M $163.2M $375.3M $341M $258.2M
 
Property Plant And Equipment $29.2M $35.3M $71.4M $68.4M $59.8M
Long-Term Investments -- -- -- -- --
Goodwill -- -- $50.6M $50.2M $47.8M
Other Intangibles $30.2M $30.2M $126.3M $121.8M $112.6M
Other Long-Term Assets $151K $265K $311K $335K $409K
Total Assets $205.8M $229.1M $624.6M $582.4M $479.4M
 
Accounts Payable $15.8M $20.1M $114.6M $69.7M $49.8M
Accrued Expenses $9.5M $12.4M $20.3M $20.9M $17.2M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $586K -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $31.5M $40M $140.1M $96.3M $71.5M
 
Long-Term Debt -- -- $266.8M $253.6M $170.5M
Capital Leases -- -- -- -- --
Total Liabilities $41.2M $49.6M $426.7M $366.9M $255.8M
 
Common Stock $68M $66M $68.1M $69.8M $72M
Other Common Equity Adj -- -- -- -- --
Common Equity $164.7M $179.5M $197.9M $215.5M $223.6M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $164.7M $179.5M $197.9M $215.5M $223.6M
 
Total Liabilities and Equity $205.8M $229.1M $624.6M $582.4M $479.4M
Cash and Short Terms $15.5M $28.4M $5.9M $5.7M $4.5M
Total Debt -- -- $270M $256.9M $173.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $19.9M $12.9M $7.3M $4.2M $3.7M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $49.2M $80.7M $118.2M $97.8M $77.1M
Inventory $80.7M $202.2M $265.1M $194.7M $171.8M
Prepaid Expenses $3.6M $7.4M $4.4M $5M $5.2M
Other Current Assets -- -- -- -- --
Total Current Assets $153.8M $309.6M $397M $309.4M $258.1M
 
Property Plant And Equipment $32.7M $60M $70.2M $61.1M $57.1M
Long-Term Investments -- -- -- -- --
Goodwill -- $49.2M $50.2M $47.8M $47.8M
Other Intangibles $30.2M $127.1M $122.6M $113.3M $110.5M
Other Long-Term Assets $355K $952K $878K $1M $1.5M
Total Assets $217.1M $546.8M $641M $532.7M $475M
 
Accounts Payable $23.8M $85.1M $101.7M $62.7M $63.1M
Accrued Expenses $11.2M $23.5M $25M $20.4M $12.7M
Current Portion Of Long-Term Debt -- $3.3M $3.3M $2.7M $8.4M
Current Portion Of Capital Lease Obligations -- -- -- -- $2.8M
Other Current Liabilities -- -- -- -- $4.5M
Total Current Liabilities $36.3M $114.4M $131.7M $89.7M $92.4M
 
Long-Term Debt -- $235.5M $281.5M $211.2M $141.9M
Capital Leases -- -- -- -- --
Total Liabilities $45.6M $360.8M $431.6M $316M $246.8M
 
Common Stock $66.6M $67.7M $69M $70.8M $73.5M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $171.4M $186M $209.3M $216.8M $228.3M
 
Total Liabilities and Equity $217.1M $546.8M $641M $532.7M $475M
Cash and Short Terms $19.9M $12.9M $7.3M $4.2M $3.7M
Total Debt -- $238.8M $284.8M $213.9M $150.3M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $17.5M $21M $20.6M $20.5M $10.4M
Depreciation & Amoritzation $5M $5.2M $11.3M $12.3M $11M
Stock-Based Compensation $662K $780K $1.3M $1.2M $1.2M
Change in Accounts Receivable -$4.5M -$3.1M -$38.1M $29.3M $17.2M
Change in Inventories -$3.9M -$845K -$114.2M -$5M $60M
Cash From Operations $18.1M $31.4M -$54.9M $19.1M $73.6M
 
Capital Expenditures $7.7M $11.7M $21.1M $6.7M $3.9M
Cash Acquisitions -- -- -$212.4M -- $17.3M
Cash From Investing -$7.7M -$11.7M -$233.5M -$1.2M $13.4M
 
Dividends Paid (Ex Special Dividend) -$4M -$4.1M -$4.3M -$4.5M -$4.6M
Special Dividend Paid
Long-Term Debt Issued -- $20M $310.1M $37.5M $55.7M
Long-Term Debt Repaid -- -$20M -$36.4M -$51.5M -$140.3M
Repurchase of Common Stock -$1.5M -$2.9M -- -- --
Other Financing Activities -- -- -$4.3M -- --
Cash From Financing -$5M -$6.9M $265.9M -$18.1M -$88.2M
 
Beginning Cash (CF) $10.2M $15.5M $28.4M $5.9M $5.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $5.3M $12.8M -$22.4M -$190K -$1.2M
Ending Cash (CF) $15.5M $28.4M $5.9M $5.7M $4.5M
 
Levered Free Cash Flow $10.4M $19.7M -$75.9M $12.4M $69.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $7.6M -$374K $5.7M $6.8M $5.3M
Depreciation & Amoritzation $1.3M $2.7M $2.9M $2.7M $2.7M
Stock-Based Compensation $189K $327K $227K $282K $314K
Change in Accounts Receivable -$12.5M $1.6M -$3.5M -$25.5M -$14.4M
Change in Inventories -$6.1M -$60.2M $20.3M $23.6M $3.1M
Cash From Operations -$819K -$39.5M -$761K $11.5M $4.5M
 
Capital Expenditures $3.1M $6.1M $2.1M $1.2M $1M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$3.1M -$6.1M $3.4M -$1.2M -$1M
 
Dividends Paid (Ex Special Dividend) -$1M -$1.1M -$1.1M -$1.1M -$1.2M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -$20M $52M $9.7M $24.1M $7.5M
Long-Term Debt Repaid $20M -$812K -$9.8M -$32.2M -$10M
Repurchase of Common Stock -$1M -- -- -- --
Other Financing Activities -- -- -- -- -$236K
Cash From Financing -$2M $50.2M -$1.1M -$9.1M -$3.9M
 
Beginning Cash (CF) $25.8M $8.4M $5.8M $3.1M $4.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$5.9M $4.6M $1.5M $1.2M -$402K
Ending Cash (CF) $19.9M $12.9M $7.3M $4.2M $3.7M
 
Levered Free Cash Flow -$3.9M -$45.6M -$2.9M $10.3M $3.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $16.3M $17.7M $26.5M $10.2M $13.3M
Depreciation & Amoritzation $5.1M $9.7M $11.8M $11.8M $10.5M
Stock-Based Compensation $678K $1.1M $1M $1.5M $1.3M
Change in Accounts Receivable $3.5M $3M -$37.8M $15.5M $22.9M
Change in Inventories $2.2M -$80.6M -$65.3M $64.2M $22.9M
Cash From Operations $31.3M -$15.1M -$35.7M $59.6M $70.8M
 
Capital Expenditures $10.3M $19M $10.9M $4M $4.2M
Cash Acquisitions -- -$207M -$5.4M $17.3M $1.7M
Cash From Investing -$10.3M -$225.9M -$10.8M $13.3M -$2.5M
 
Dividends Paid (Ex Special Dividend) -$4.1M -$4.2M -$4.5M -$4.6M -$4.6M
Special Dividend Paid
Long-Term Debt Issued -- $294.7M $65.9M $57.5M $183.6M
Long-Term Debt Repaid -- -$52.1M -$20.8M -$129.2M -$247.1M
Repurchase of Common Stock -$3.5M -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -$7.5M $234M $40.9M -$76M -$68.9M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $13.5M -$7M -$5.6M -$3M -$535K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $21M -$34.1M -$46.6M $55.6M $66.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $11.2M $8M $14M $3.7M $6.6M
Depreciation & Amoritzation $3.8M $8.2M $8.8M $8.3M $7.8M
Stock-Based Compensation $586K $935K $701K $922K $965K
Change in Accounts Receivable $1.3M $7.4M $7.8M -$6M -$290K
Change in Inventories -$3.9M -$83.6M -$34.7M $34.5M -$2.6M
Cash From Operations $18.1M -$28.5M -$9.3M $31.1M $28.4M
 
Capital Expenditures $8.6M $15.9M $5.7M $2.9M $3.2M
Cash Acquisitions -- -$207M -- $17.3M $1.7M
Cash From Investing -$8.6M -$222.8M -$208K $14.4M -$1.5M
 
Dividends Paid (Ex Special Dividend) -$3.1M -$3.2M -$3.4M -$3.4M -$3.5M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $274.7M $30.5M $50.5M $178.4M
Long-Term Debt Repaid -- -$32.1M -$16.5M -$94.1M -$200.9M
Repurchase of Common Stock -$2M -- -- -- --
Other Financing Activities -- -$4.3M -- -- -$2.3M
Cash From Financing -$5.1M $235.9M $10.9M -$47M -$27.7M
 
Beginning Cash (CF) $85.6M $45.6M $26.7M $13.7M $11.6M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $4.4M -$15.4M $1.4M -$1.5M -$765K
Ending Cash (CF) $90M $30.2M $28M $12.3M $10.9M
 
Levered Free Cash Flow $9.5M -$44.3M -$15M $28.2M $25.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock